Clinical Trials in Minneapolis

Showing 7921-7940 of 11,007 trials

CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant

NCT00369291

RATIONALE: Giving CpG 7909 after an autologous stem cell transplant may make a stronger immune response and prevent or delay the recurrence of cancer. PURPOSE: This phase I trial is studying the side effects and best dose of CpG 7909 in treating patients who have undergone autologous stem cell transplant.

Germ Cell TumorLeukemiaLymphoma+1 more

Masonic Cancer Center, University of Minnesota19 participantsStarted Sep 2003

Minneapolis, Minnesota, United States

COMPLETEDPhase 1< 1 mile

Clinical Trial of Trametes Versicolor in Women With Breast Cancer

NCT00680667

RATIONALE: Coriolus versicolor mushroom extract may slow the growth of cancer cells and may be an effective treatment for breast cancer. PURPOSE: This phase I trial is studying the side effects and best dose of coriolus versicolor extract in treating women with stage I, stage II, or stage III breast cancer who have finished radiation therapy.

Breast Cancer

Masonic Cancer Center, University of Minnesota11 participantsStarted Apr 2007

Minneapolis, Minnesota, United States • Kenmore, Washington, United States

TERMINATEDPhase 1< 1 mile

Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

NCT00725062

RATIONALE: A donor peripheral stem cell transplant helps stop the growth of cancer cells. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. Once the donated stem cells begin working, the patient's immune system may see the remaining cancer cells as not belonging in the patient's body and destroy them. Giving an infusion of donor T cells may helps stop the patient's immune system from rejecting the donor's stem cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of donor T cells in treating patients with high-risk hematologic cancer who are undergoing donor peripheral blood stem cell transplant. Note: Only Phase I portion of study was performed. Due to slow accrual, study was closed before Phase II portion of study.

Graft Versus Host DiseaseLeukemiaLymphoma+2 more

Masonic Cancer Center, University of Minnesota3 participantsStarted Jun 2008

Minneapolis, Minnesota, United States

CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant

Clinical Trial of Trametes Versicolor in Women With Breast Cancer

Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Find Trials by Condition in Minneapolis

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites

Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)

A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Safety Escalating Repeat IV, in Stroke Patients

Effect of Endometrial Biopsy on in Vitro Fertilization Pregnancy Rates - a Multicenter Study

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

A Study of ABT-806 in Subjects With Advanced Solid Tumor Types